Precigen, Inc. (PGEN)
7.195
-0.16
(-2.18%)
USD |
NASDAQ |
Oct 15, 16:00
7.195
0.00 (0.00%)
After-Hours: 20:00
Precigen Cash from Operations (TTM) : -114.16M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -114.16M |
| March 31, 2026 | -115.33M |
| December 31, 2025 | -87.83M |
| September 30, 2025 | -72.61M |
| June 30, 2025 | -66.28M |
| March 31, 2025 | -70.41M |
| December 31, 2024 | -68.17M |
| September 30, 2024 | -75.70M |
| June 30, 2024 | -69.97M |
| March 31, 2024 | -62.63M |
| December 31, 2023 | -66.93M |
| September 30, 2023 | -66.56M |
| June 30, 2023 | -73.36M |
| March 31, 2023 | -64.65M |
| December 31, 2022 | -65.04M |
| September 30, 2022 | -64.24M |
| June 30, 2022 | -57.45M |
| March 31, 2022 | -58.17M |
| December 31, 2021 | -55.77M |
| September 30, 2021 | -57.65M |
| June 30, 2021 | -59.63M |
| March 31, 2021 | -65.66M |
| December 31, 2020 | -77.02M |
| September 30, 2020 | -92.69M |
| June 30, 2020 | -100.84M |
| Date | Value |
|---|---|
| March 31, 2020 | -120.44M |
| December 31, 2019 | -135.93M |
| September 30, 2019 | -141.15M |
| June 30, 2019 | -142.82M |
| March 31, 2019 | -137.59M |
| December 31, 2018 | -124.24M |
| September 30, 2018 | -120.76M |
| June 30, 2018 | -113.95M |
| March 31, 2018 | -109.34M |
| December 31, 2017 | -104.14M |
| September 30, 2017 | -94.45M |
| June 30, 2017 | -81.19M |
| March 31, 2017 | -70.07M |
| December 31, 2016 | -48.99M |
| September 30, 2016 | -12.46M |
| June 30, 2016 | 49.18M |
| March 31, 2016 | 45.10M |
| December 31, 2015 | 35.67M |
| September 30, 2015 | 14.29M |
| June 30, 2015 | -45.24M |
| March 31, 2015 | -42.38M |
| December 31, 2014 | -19.86M |
| September 30, 2014 | -21.03M |
| June 30, 2014 | -30.24M |
| March 31, 2014 | -29.92M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Anika Therapeutics, Inc. | 5.977M |
| Aldeyra Therapeutics, Inc. | -22.02M |
| Repligen Corp. | 134.86M |
| AC Immune SA | -- |
| Amgen, Inc. | 12.48B |